pubs.acs.org/joc
coupling with boronic acids,4,5 organostannanes,6 or arylsil-
Desulfitative Cross-Coupling of Protecting Group-
Free 2-Thiouracil Derivatives with Organostannanes
oxanes7 and allows access to original, and previously unob-
tained, functionalizations.8 The scope of this novel base free
reaction has been extended considerably to enable the coupling
reaction between organosulfur and organometallic reagents to
overcome the failure encountered by the traditional C-C bond
formation method.9 In independent studies, our group has
shown that the carboxylate counterion is not essential for the
catalytic cycle to proceed with stannane derivatives, and can be
efficiently replaced by the readily accessible copper(I) bromide-
‡
Qi Sun,†,‡ Franck Suzenet,*,‡ and Gerald Guillaumet
ꢀ
†School of Pharmaceutical Science, Peking University, 38,
Xueyuan Road, Haidian District, Beijing, China, 100191, and
‡
ꢀ
Institut de Chimie Organique et Analytique, Universite
d’Orleꢀans, UMR-CNRS 6005, rue de Chartres, BP 6759,
ꢀ
45067 Orleans cedex 2, France
dimethyl sulfide complex (CuBr Me2S).10 This approach has
3
Received February 24, 2010
been recently successfully applied to various substrates.11
In the context of the synthesis of combinatorial libraries of
2-aryl-1,4-dihydropyrimidines as potential non-nucleosidic
inhibitors of hepatitis B virus replication, Kappe and co-
workers developed a direct C-C cross-coupling of cyclic
thioureas containing a latent free-thiol functionality under
microwave conditions in high yields.12 This promising de-
sulfitative coupling was successfully applied to thioamide
fragments13 and oxazolinethiones14 with boronic acids and
stannanes, and extended to arylsiloxanes for the former and
a variety of terminal alkynes for the latter.15
2-Thiouracil (1) and related modified pyrimidine nucleo-
bases are important reagents for the synthesis of different
kinds of heterocycles with potential biological activity. Their
special structures have also emerged as a building block in
natural or synthetic molecules. Furthermore, uracil has been
proposed as the central scaffold in the butterfly strategies for
the synthesis of original non-nucleoside reverse transcriptase
inhibitors (NNRTIs).16 Therefore the acyl thiourea moiety
(-NH-C(S)-NH-C(O)-), which can also be found in
many easily accessible modified pyrimidines, appeared to
be an interesting function in order to access various sub-
stituted pyrimidin-4-ones. In this paper, we report a unique
and efficient copper bromide mediated pallado-catalyzed
coupling of protecting group-free 2-thiouracil derivatives
with organostannanes.
We here report a unique and efficient copper bromide
mediated pallado-catalyzed coupling of protecting group-
free 2-thiouracil derivatives with organostannanes. The
nature of the copper appears to be crucial for successful
cross coupling.
Heterocycle structures have played an important role in
lead discovery and biological activities in the pharmaceutical
industry and academic research.1 Metal-catalyzed coupling
protocols have developed into powerful tools for synthetic
chemists and have proved highly successful in the construc-
tion and functionalization of heteroaromatic series over the
past two decades.2 However, the ability to selectively form
site specific covalent bonds within a sensitive molecule under
mild conditions and without the need for protection-
deprotection remains an attractive challenge for organic
chemists.
Most transition metal cross-coupling procedures involve
the interaction of an electrophilic organohalide (or related
substrate) with a nucleophilic organometallic reagent. The
limited stability and/or accessibility of the corresponding
heteroaromatic derivatives appears somewhat problematic
and led Liebeskind and Srogl to develop a new efficient
palladium-catalyzed cross-coupling reaction involving thiol
ester3 and thioether4 type species. This method requires a
stoichiometric amount of a copper(I) carboxylate for efficient
Encouraged by the success of Kappe’s work,12,13 we ex-
plored the Liebeskind-Srogl cross-coupling between the CdS
of 2-thiouracil 1 with phenylboronic acid 2. Unfortunately,
(6) Egi, M.; Liebeskind, L. S. Org. Lett. 2003, 5, 801.
(7) Mehta, V. P.; Sharma, A.; Van der Eycken, E. Adv. Synth. Catal. 2008,
350, 2174.
(8) (a) Leconte, N.; Keromnes-Wuillaume, A.; Suzenet, F.; Guillaumet,
€
G. Synlett 2007, 204. (b) Leconte, N.; Pellegatti, L.; Tatibouet, A.; Suzenet,
F.; Rollin, P.; Guillaumet, G. Synthesis 2007, 857. (c) Alphonse, F.-A.;
Suzenet, F.; Keromnes, A.; Lebret, B.; Guillaumet, G. Synthesis 2004, 2893.
ꢀ
(9) Prokopcova, H.; Kappe, C. O. Angew. Chem., Int. Ed. 2008, 47, 3674.
(10) Alphonse, F.-A.; Suzenet, F.; Keromnes, A.; Lebret, B.; Guillaumet,
G. Org. Lett. 2003, 5, 803.
(11) (a) Richardson, C.; Rewcastle, G. W.; Hoyer, D.; Denny, W. A.
€
J. Org. Chem. 2005, 70, 7436. (b) Schleiss, J.; Rollin, P.; Tatibouet, A. Angew.
Chem., Int. Ed. 2010, 49, 577.
(12) Lengar, A.; Kappe, C. O. Org. Lett. 2004, 6, 771.
(13) (a) Arshad, N.; Hashim, J.; Kappe, C. O. J. Org. Chem. 2009, 74,
(1) (a) Horton, D. A.; Bourne, G. T.; Smythe, M. L. Chem. Rev. 2003, 103,
893. (b) Font, D.; Heras, M.; Villalgordo, J. M. J. Comb. Chem. 2003, 5, 311.
(2) Miyaura, N.; Suzuki, A. Chem. Rev. 1995, 95, 2457.
(3) (a) Savarin, C.; Srogl, J.; Liebeskind, L. S. Org. Lett. 2000, 2, 3229. (b)
Liebeskind, L. S.; Srogl, J. J. Am. Chem. Soc. 2000, 122, 11260.
(4) Liebeskind, L. S.; Srogl, J. Org. Lett. 2002, 4, 979.
ꢀ
5118. (b) Prokopcova, H.; Kappe, C. O. J. Org. Chem. 2007, 72, 4440.
(14) Silva, S.; Tardy, S.; Routier, S.; Suzenet, F.; Tatibouet, A.; Rauter,
A. P.; Rollin, P. Tetrahedron Lett. 2008, 49, 5583.
(15) Silva, S.; Sylla, B.; Suzenet, F.; Tatibouet, A.; Rauter, A. P.; Rollin,
P. Org. Lett. 2008, 10, 853.
(5) (a) Savarin, C.; Srogl, J.; Liebeskind, L. S. Org. Lett. 2001, 3, 91. (b)
Alphonse, F.-A.; Suzenet, F.; Keromnes, A.; Lebret, B.; Guillaumet, G.
Synlet. 2002, 447.
(16) (a) Dasa, K.; Lewib, P. J.; Hughesc, S. H.; Arnold, E. Prog. Biophys.
Mol. Biol. 2005, 88, 209. (b) Yu, M.; Liu, X.; Li, Z.; Liu, S.; Pannecouque, C.;
De Clercq, E. Bioorg. Med. Chem. 2009, 17, 7749.
DOI: 10.1021/jo1003482
r
Published on Web 04/01/2010
J. Org. Chem. 2010, 75, 3473–3476 3473
2010 American Chemical Society